Corvus Pharmaceuticals to Provide Business Update and Third Quarter 2025 Financial Results on November 4, 2025
Corvus Pharmaceuticals (NASDAQ: CRVS) will provide a business update and report third quarter 2025 financial results on November 4, 2025. The company will host a conference call and live webcast at 4:30 pm ET / 1:30 pm PT. Participants can dial 1-800-717-1738 (toll-free U.S.) or 1-646-307-1865 (international), or join via the instant telephone access link and the company’s investor relations webcast page. A replay of the webcast will be available on the Corvus website for 90 days.
Corvus Pharmaceuticals (NASDAQ: CRVS) fornirà un aggiornamento sull’attività e riporterà i risultati finanziari del terzo trimestre 2025 il 4 novembre 2025. L'azienda terrà una conference call e una webcast in diretta alle 16:30 ET / 13:30 PT. I partecipanti possono chiamare il numero 1-800-717-1738 (US senza costi) o 1-646-307-1865 (internazionale), oppure unirsi tramite il link di accesso telefonico istantaneo e la pagina webcast degli investitori dell'azienda. Una riproduzione della webcast sarà disponibile sul sito Corvus per 90 giorni.
Corvus Pharmaceuticals (NASDAQ: CRVS) proporcionará una actualización comercial e informará los resultados financieros del tercer trimestre de 2025 el 4 de noviembre de 2025. La compañía celebrará una llamada de conferencia y una transmisión en vivo por Internet a las 18:30 hora del Este / 15:30 hora del Pacífico. Los participantes pueden marcar el 1-800-717-1738 (EE. UU. sin cargo) o el 1-646-307-1865 (internacional), o unirse a través del enlace de acceso telefónico instantáneo y la página de webcast de relaciones con inversionistas de la empresa. Una repetición de la transmisión estará disponible en el sitio web de Corvus durante 90 días.
Corvus Pharmaceuticals (NASDAQ: CRVS) 는 2025년 3분기 재무 실적을 2025년 11월 4일에 발표하는 사업 업데이트를 제공하고 동부 표준시 16:30 / 태평양 표준시 13:30에 컨퍼런스 콜과 라이브 웹캐스트를 주최합니다. 참가자는 미국 내 무료전화 1-800-717-1738(미국) 또는 1-646-307-1865(해외)로 전화하거나 즉시 전화 접속 링크와 회사의 투자자 관계 웹캐스트 페이지를 통해 참여할 수 있습니다. 웹캐스트의 재생은 Corvus 웹사이트에서 90일간 제공됩니다.
Corvus Pharmaceuticals (NASDAQ : CRVS) fournira une mise à jour commerciale et publiera les résultats financiers du troisième trimestre 2025 le 4 novembre 2025. La société animera une conférence téléphonique et une webdiffusion en direct à 16 h 30 HE / 13 h 30 HP. Les participants peuvent composer le 1-800-717-1738 (numéro gratuit États‑Unis) ou le 1-646-307-1865 (international), ou rejoindre via le lien d’accès téléphonique instantané et la page webcast des relations investisseurs de la société. Une rediffusion de la webdiffusion sera disponible sur le site Web de Corvus pendant 90 jours.
Corvus Pharmaceuticals (NASDAQ: CRVS) wird ein Geschäftsupdate geben und die Finanzergebnisse des dritten Quartals 2025 am 4. November 2025 berichten. Das Unternehmen wird eine Konferenztelefonat und einen Live-Webcast um 16:30 Uhr ET / 13:30 Uhr PT abhalten. Die Teilnehmer können die kostenfreie Nummer 1-800-717-1738 (US) oder 1-646-307-1865 (international) wählen oder über den sofortigen Telefondatenzugang-Link und die Webcast-Seite der Investor Relations teilnehmen. Eine Aufzeichnung des Webcasts wird auf der Corvus-Website für 90 Tage verfügbar sein.
ستیقدم شركة Corvus Pharmaceuticals (ناسداك: CRVS) بتحديث أعمال وستعلن عن نتائجها المالية للربع الثالث من عام 2025 في 4 نوفمبر 2025. ستستضيف الشركة مكالمة مؤتمر وبثاً مباشراً عبر الويب في 16:30 بالتوقيت الشرقي / 13:30 بتوقيت المحيط الهادئ. يمكن للمشاركين الاتصال بالرقم 1-800-717-1738 (الولايات المتحدة مجانا) أو 1-646-307-1865 (دولي)، أو الانضمام عبر رابط الوصول الهاتفي الفوري وصفحة بث المستثمرين على شبكة الإنترنت للشركة. ستتوفر إعادة بث الويب على موقع كورفوس لمدة 90 يوماً.
Corvus Pharmaceuticals（纳斯达克股票代码：CRVS）将提供业务更新并在 2025 年第三季度财务业绩中披露结果，时间为 2025 年 11 月 4 日。公司将于 美东时间 16:30 / 太平洋时间 13:30 举行电话会议并进行在线网络广播。参与者可以拨打美国免费电话 1-800-717-1738，或国际电话 1-646-307-1865，亦可通过即时电话接入链接以及公司的投资者关系网络广播页面加入。网络广播的回放将在 Corvus 网站上提供 90 天。
- None.
- None.
Company to host conference call and webcast at 4:30 pm ET / 1:30 pm PT
SOUTH SAN FRANCISCO, Calif., Oct. 28, 2025 (GLOBE NEWSWIRE) -- Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS), a clinical-stage biopharmaceutical company, today announced that the company will host a conference call and webcast on November 4, 2025 at 4:30 pm ET (1:30 pm PT) to provide a business update and report third quarter 2025 financial results.
The conference call can be accessed by dialing 1-800-717-1738 (toll-free domestic) or 1-646-307-1865 (international) or by clicking on this link for instant telephone access to the event. The live webcast may be accessed via the investor relations section of the Corvus website. A replay of the webcast will be available on Corvus’ website for 90 days.
About Corvus Pharmaceuticals
Corvus Pharmaceuticals is a clinical-stage biopharmaceutical company pioneering the development of ITK inhibition as a new approach to immunotherapy for a broad range of cancer and immune diseases. The Company’s lead product candidate is soquelitinib, an investigational, oral, small molecule drug that selectively inhibits ITK. Its other clinical-stage candidates are being developed for a variety of cancer indications. For more information, visit www.corvuspharma.com or follow the Company on LinkedIn.
INVESTOR CONTACT:
Leiv Lea
Chief Financial Officer
Corvus Pharmaceuticals, Inc.
+1-650-900-4522
llea@corvuspharma.com
MEDIA CONTACT:
Sheryl Seapy
Real Chemistry
+1-949-903-4750
sseapy@realchemistry.com
FAQ
When will Corvus (CRVS) report third quarter 2025 results?
How can investors join the Corvus (CRVS) November 4, 2025 conference call?
Where can I watch the Corvus (CRVS) live webcast for the Q3 2025 update?
Will there be a replay of the Corvus (CRVS) November 4, 2025 webcast?
What time is the Corvus (CRVS) call for international participants on November 4, 2025?
